GlassScriptPhysician profile
David L Helfet
NPI 1972510154
$264,630.40
in general payments reported to CMS, 2019-2025
10 companies · $62.92 in 2025
The $62.92 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242K · 2020: $77.30 · 2022: $15K · 2023: $6,633 · 2024: $96.74 · 2025: $62.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,332 · Consulting Fee: $3,210 · Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,331.66 |
| Consulting Fee | $3,210.24 |
| Food and Beverage | $250.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $240,275.40 | 2019 | |
| Synthes USA Products LLC | $12,192.43 | 2019-2022 | |
| Illuminoss Medical, INC. | $6,953.39 | 2022-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Medical Device Business Services, INC. | $3,600.00 | 2022 | |
| Arthrex, INC. | $1,441.20 | 2022-2025 | |
| Dynasplint Systems INC. | $77.30 | 2020 | |
| Depuy Synthes Sales INC. | $63.64 | 2023 | Na |
| Molnlycke Health Care US, LLC | $27.04 | 2023 | Avance |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,765,466.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Helfet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.